The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?

SIMPLE SUMMARY: The study investigates the potential use of metformin, a medication commonly prescribed for type 2 diabetes, in the treatment of hepatocellular carcinoma (HCC). Metformin has been gaining attention for its possible anticancer properties beyond its antidiabetic effects. The study expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadakos, Stavros P., Ferraro, Daniele, Carbone, Gabriele, Frampton, Adam Enver, Vennarecci, Giovanni, Kykalos, Stylianos, Schizas, Dimitrios, Theocharis, Stamatios, Machairas, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295995/
https://www.ncbi.nlm.nih.gov/pubmed/37370771
http://dx.doi.org/10.3390/cancers15123161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295995/
https://www.ncbi.nlm.nih.gov/pubmed/37370771
http://dx.doi.org/10.3390/cancers15123161

Ejemplares similares